Albireo Earnings Before Interest Taxes and Depreciation Amortization USD from 2010 to 2023

Summary

ALBODelisted Stock

USD 44.15 0.75 1.67%

Albireo Pharma Earnings Before Interest Taxes and Depreciation Amortization USD yearly trend continues to be very stable with very little volatility. Earnings Before Interest Taxes and Depreciation Amortization USD are likely to drop to -19,250,147. During the period from 2010 to 2023, Albireo Pharma Earnings Before Interest Taxes and Depreciation Amortization USD quarterly data regression pattern had range of 91,048,000 and median of (19,250,147). Albireo Pharma Weighted Average Shares is very stable at the moment as compared to the past year. Albireo Pharma reported last year Weighted Average Shares of 22.1 Million. As of 20th of March 2023, Weighted Average Shares Diluted is likely to grow to about 23.8 M, while Consolidated Income is likely to drop (33 M).

Check Albireo Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Albireo main balance sheet or income statement drivers, such as Direct Expenses of 1.2 M, Cost of Revenue of 1.2 M or Gross Profit of 48.7 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.0502, PPandE Turnover of 67.56 or Receivables Turnover of 6.79. Albireo financial statements analysis is a perfect complement when working with Albireo Pharma Valuation or Volatility modules. It can also supplement various Albireo Pharma Technical models . Please continue to Trending Equities.

Albireo Earnings Before Interest Taxes and Depreciation Amortization USD Breakdown

Showing smoothed Earnings Before Interest Taxes and Depreciation Amortization USD of Albireo Pharma with missing and latest data points interpolated. Earnings Before Interest Taxes and Depreciation Amortization EBITDA in USD; converted by US Dollar Exchange Rate.Albireo Pharma's Earnings Before Interest Taxes and Depreciation Amortization USD historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Albireo Pharma's overall financial position and show how it may be relating to other accounts over time.

Earnings Before Interest Taxes and Depreciation Amortization USD

10 Years Trend

Down

Slightly volatile

Compare to Others All Fundamentals

Earnings Before Interest Taxes and Depreciation Amortization USD

Timeline

Albireo Earnings Before Interest Taxes and Depreciation Amortization USD Regression Statistics

	Arithmetic Mean	(26,636,411)
	Geometric Mean	19,804,843
	Coefficient Of Variation	(90.49)
	Mean Deviation	16,381,681
	Median	(19,250,147)
	Standard Deviation	24,103,244
	Range	91,048,000
	R-Value	(0.36)
	R-Squared	0.13
	Significance	0.21
	Slope	(2,052,430)

Albireo Earnings Before Interest Taxes and Depreciation Amortization USD History

	2023	-19.3 M
	2022	-17.8 M
	2021	-19.8 M
	2020	-96.1 M
	2019	-57.3 M
	2018	-41.2 M
	2017	-24.2 M
	2016	-15 M
	2014	-5 M
	2013	-13.5 M
	2012	-18.7 M

About Albireo Pharma Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Albireo Pharma income statement, its balance sheet, and the statement of cash flows. Albireo Pharma investors use historical funamental indicators, such as Albireo Pharma's Earnings Before Interest Taxes and Depreciation Amortization USD, to determine how well the company is positioned to perform in the future. Although Albireo Pharma investors may use each financial statement separately, they are all related. The changes in Albireo Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Albireo Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Albireo Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Albireo Pharma. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for 2023
Earnings Before Interest Taxes and Depreciation Amortization EBITDA	-17.8 M	-19.3 M
Earnings before Tax	-30.6 M	-33 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Albireo Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Focused Opportunities Now

Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences

All Next

Launch Module

Pair Trading with Albireo Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Albireo Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Albireo Pharma will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to Albireo Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Albireo Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Albireo Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Albireo Pharma to buy it.

The correlation of Albireo Pharma is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Albireo Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Albireo Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Albireo Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Please continue to Trending Equities. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Consideration for investing in Albireo Stock

If you are still planning to invest in Albireo Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albireo Pharma's history and understand the potential risks before investing.

	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Commodity Channel Index Use Commodity Channel Index to analyze current equity momentum
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC